Question 1

What are the potential benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma clinical trial (NCT01392716). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the treatment be administered, and what should I expect during the sessions?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma clinical trial (NCT01392716). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while receiving rituximab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma clinical trial (NCT01392716). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma clinical trial (NCT01392716). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or complications during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma clinical trial (NCT01392716). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel requirements for participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma clinical trial (NCT01392716). Contact the study team or your healthcare provider for specific answers.

What this study is about